Feedback / Questions
Elfabrio (pegunigalsidase alfa-iwxj) - Protalix, Chiesi
Replagal (agalsidase alfa) - Samaritan Pharma, Takeda
Long-term safety and efficacy of pegunigalsidase alfa in patients who switched from agalsidase alfa
(SSIEM 2026)
-
Aug 17, 2026 -
Abstract #P-361B; Pres time: Aug 26, 2026; 05:30 PM - 06:30 PM; Location: Hall 4&5;
No abstract available
Clinical
https://airdrive.eventsair.com/eventsairwesteuprod/production-confedent-public/d8fd39c573ab4444a6cbed895a5da0bb
Hopkin Robert
Aug 17, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next